Memphis Co. for Pharmaceutical Net Profit 81% Down; H1

By Yomna Yasser On Sep 9, 2012

Memphis Co. for Pharmaceutical and Chemical Industries (MPCI.CA) reported a net profit of EGP 1.044 million during the first half of 2012, 81% down from a year earlier net profit of EGP 5.507 million.

Revenues through H1/2012 fell to EGP 278.988 million, compared to EGP 350.989 million for H1/2011.

Gross profit – after excluding the cost of revenues – went down to EGP 13.973 million during H1/2012, compared to EGP 20.379 million for H1/2011.

Moreover, working capital declined to EGP 37.077 million during H1/2012, compared to EGP 47.362 million a year earlier.

Total investments dropped to EGP 100.258 million for H1/2012, compared to EGP 110.143 million for H1/2011.